CJC-1295 DAC (Modified GRF 1-29 Drug Affinity Complex) – 2MG per vial

Clinical Test Expectation – Human Subjects CJC-1295 DAC : Long Release – Increased growth hormone secretion and IGF-1 Levels with no increase in prolactin. Increased body weight and length through increased protein synthesis. Increased muscle growth and bone density. Improved immune function, cognition and memory. Increased collagen production, fat loss and cellular repair and regeneration.
Strength – 2MG per vial

Introduction
CJC 1295 DAC is often used to stimulate muscle development. This works by increasing the blood level of hormones associated with growth. It can increase muscle mass and strength, decrease body fat, improve injury recovery time, and even improve sleep quality and cognitive function.

CJC-1295 + DAC has shown some amazing results as a growth hormone releasing hormone (GHRH) analog. Not only has CJC-1295 shown the ability to increase growth hormone and IGF-I secretion and its benefits, but it has been able to do so in very large amounts. Recent research studies have shown that CJC – 1295 stimulates GH and IGF-1 Secretion, and will keep a steady increase of HGH and IGF-1 with no increase in prolactin, leading to intense fat loss, and increases protein synthesis.

CJC-1295 + DAC is a long acting Growth Hormone Releasing Hormone, which causes the anterior pituitary  to release more growth hormone. GHRH is released in pulses in the body, which alternate with corresponding pulses of somatostatin (growth-hormone inhibiting-hormone). Clinical Research was first conducted for CJC-1295 during the mid-2000s. The objective of the peptide was to treat visceral fat deposits in obese AIDS patients, as increased levels of exogenous HGH are presumed to increase lipolysis (fat loss). The clinical research was ultimately successful for most research subjects. Ghrelin, released from the gut, which circulates and acts as a hunger hormone, has synergistic activity in the body with GHRH and also suppresses somatostatin to make way for the GHRH pulse. Studies shows that combining a GHRP-6 with CJC-1295 + DAC, significantly increase the release of GH and IGF-1 production without an increase in prolactin. An example of a GHRP (GH Releasing Peptide) is Hexarelin or GHRP-2. CJC-1295 + DAC is a exceptionally designed peptide and is known for being the finest of the hGH secretogues. The DAC (Drug Affinity Complex) portion increases the half-life by binding with serum albumin and protects the CJC-1295 DAC peptide from degradation. This was formed when a lysine link was bounded to DACs to a reactive chemical called maleimidoproprionic acid (MPA).

Dosing Details
You inject 2.5ml water into the vial of CJC1295 DAC from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 60 (6 units) on the syringe twice a week evenly spaced on the days each morning before breakfast and inject it into the tummy under the skin into the fatty skin layer. A vial should last 2 weeks.

How long will a vial last ?
A vial should last 14 days.